Respuesta de insulina a la carga oral de glucosa en niños y adolescentes con sobrepeso y obesidad

Revista Venezolana de Endocrinología y Metabolismo 04/2011; 9(1):12-19.

ABSTRACT Objectives: To evaluate the insulin response to an oral glucose load in children and adolescents with overweight and obesity. Methods: Two-hundred subjects attending the out-patient endocrinology clinic of the Hospital JM de Los Ríos, Caracas, Venezuela, with unspecific symptoms of hypoglycemia or body weight excess were selected. Hypoglycemia and/or carbohydrate metabolism abnormalities were ruled out. Subjects were categorized according pubertal stage and body mass index (BMI); Group A: pre-pubertal: (Tanner I), BMI <P90); Group B: adolescents (Tanner II-V), BMI <P90; Group C: pre-pubertal (Tanner I), BMI >P90; Group D: adolescents (Tanner II-V), BMI> P90. Plasma glucose and insulin were measured at baseline and 30, 60 and 120 minutes after oral glucose load (1.75 g/kg). Results: Basal insulin was significantly higher in adolescents and groups with abnormal body weight, compared with pre pubertal and normal weight respectively. All groups showed a peak insulin response at 30 min post oral glucose load; the insulin response was higher as BMI and pubertal stage increased with the highest values in adolescents and body weight excess (p<0,01). No significant differences were observed according diabetes mellitus family history. Conclusions: Our results suggest that oral glucose tolerance test might be useful in children and adolescents with body weight excess in order to identify the subjects at risk of metabolic disorders leading to improve prevention strategies in this young population.

Download full-text


Available from: Joalice Villalobos, Jun 29, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to examine the influence of positive family history (FH) of type 2 diabetes (T2D) on aspects of insulin resistance in prepubertal children. Twenty-one children (Tanner stage I or II) with a positive FH were compared with children with no FH. FH was defined by presence of T2D in a parent or grandparent as assessed by interview. The two groups of children were matched for age, gender, Tanner stage, ethnicity, geographical location, and body fat mass using a pair-matched design. These 21 pairs of children included Caucasian, African American, and Hispanic children who were studied either in Birmingham, Alabama, or Los Angeles, California, using similar techniques. Insulin sensitivity (S(I)) and the acute insulin response to glucose (AIR) were determined by an iv glucose tolerance test and minimal modeling, and body composition was determined by dual-energy x-ray absorptiometry. There were no significant differences in fasting glucose or insulin, S(I), AIR, the disposition index (product of S(I) and AIR), or body composition between children with a FH vs. those without a FH of T2D, and there were no significant differences in these parameters when the data were analyzed separately in each ethnic group. In conclusion, a positive FH for T2D does not seem to have any significant effect on insulin sensitivity, as assessed by the minimal model and associated risk factors for T2D in young children.
    Journal of Clinical Endocrinology &amp Metabolism 02/2003; 88(1):192-5. DOI:10.1210/jc.2002-020917 · 6.31 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adiposity in childhood is often associated with metabolic abnormalities and accompanied by a dysregulation of the coagulation and fibrinolytic systems. We studied the interrelationship of metabolic and hemostatic parameters and explored their relationship with measures of adiposity and fat distribution in obese children. In 34 obese boys (mean age, 11.7 years) and 57 obese girls (12.1 years), blood samples were determined for insulin, glucose, triglycerides, fibrinogen, plasminogen activator inhibitor-1 (PAI-1), and tissue-type plasminogen activator-antigen (tPA-Ag). Body composition was assessed by means of impedance. Waist (Wc) and hip circumference were measured. The thickness of subcutaneous adipose tissue-layers (SAT-layers) was measured at 15 different body sites (from 1-neck to 15-calf) by means of the optical device, Lipometer. Overall subcutaneous fatness (SAT) was calculated and SAT-distribution was estimated by means of factor analysis. Significant correlations were found between different measures of adiposity and Wc with metabolic parameters. Fibrinogen was mainly associated with upper body subcutaneous fatness (factor 1) in boys. In girls, hemostatic parameters were associated with nearly all measures of adiposity and also with factor 1 and SAT. Regression analysis showed that factor 1 together with PAI-1 (both P <.0001) contribute to fibrinogen (adjusted [adj], R(2) =.30). PAI-1 together with trigylcerides (both P <.0001) and age (P <.04) were main determinants for tPA-Ag (adj, R(2) =.41). tPA-Ag (P <.0001) together with glucose (P <.001, negative slope), fibrinogen (P <.001, negative slope), and percentage fat mass (%FM) (P <.01) contributed to PAI-1 (adj, R(2) =.54). These results favor the concept of an interrelationship between metabolic and hemostatic parameters resulting from increased adiposity, perhaps influenced by pubertal development of children. Although upper body subcutaneous fatness was found to be a main correlate of metabolic and hemostatic parameters, it remains to be investigated whether this type of subcutaneous fat distribution is involved in the expression of metabolic and hemostatic risk factors and participates in the dysregulation of the hemostatic system in the state of childhood obesity.
    Metabolism 07/2001; 50(6):681-7. DOI:10.1053/meta.2001.22562 · 3.61 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Insulin resistance plays an important role in the pathophysiology of diabetes and is associated with obesity and other cardiovascular risk factors. The "gold standard" glucose clamp and minimal model analysis are two established methods for determining insulin sensitivity in vivo, but neither is easily implemented in large studies. Thus, it is of interest to develop a simple, accurate method for assessing insulin sensitivity that is useful for clinical investigations. We performed both hyperinsulinemic isoglycemic glucose clamp and insulin-modified frequently sampled iv glucose tolerance tests on 28 nonobese, 13 obese, and 15 type 2 diabetic subjects. We obtained correlations between indexes of insulin sensitivity from glucose clamp studies (SI(Clamp)) and minimal model analysis (SI(MM)) that were comparable to previous reports (r = 0.57). We performed a sensitivity analysis on our data and discovered that physiological steady state values [i.e. fasting insulin (I(0)) and glucose (G(0))] contain critical information about insulin sensitivity. We defined a quantitative insulin sensitivity check index (QUICKI = 1/[log(I(0)) + log(G(0))]) that has substantially better correlation with SI(Clamp) (r = 0.78) than the correlation we observed between SI(MM) and SI(Clamp). Moreover, we observed a comparable overall correlation between QUICKI and SI(Clamp) in a totally independent group of 21 obese and 14 nonobese subjects from another institution. We conclude that QUICKI is an index of insulin sensitivity obtained from a fasting blood sample that may be useful for clinical research.
    Journal of Clinical Endocrinology &amp Metabolism 08/2000; 85(7):2402-10. DOI:10.1210/jcem.85.7.6661 · 6.31 Impact Factor